Johnson Pharmacare Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	0.8	0.14	0.01	0.02	0.41
Short-Term Investments	22.26	-	-	-	-
Cash & Short-Term Investments	23.06	0.14	0.01	0.02	0.41
Cash Growth	16026.57%	921.43%	-22.22%	-95.57%	-82.55%
Accounts Receivable	-	-	-	-	10.5
Receivables	-	-	-	-	10.5
Other Current Assets	-	13.5	-	-	-
Total Current Assets	23.06	13.64	0.01	0.02	10.91
Long-Term Investments	197.25	422.92	455.58	455.58	541.79
Other Long-Term Assets	-	-	-	-	-0
Total Assets	220.31	579.26	598.3	598.3	599.81
Other Current Liabilities	1.94	11.51	11.26	9.76	11.35
Total Current Liabilities	1.94	11.51	11.26	9.76	11.35
Long-Term Debt	214.02	6.05	19.5	19.05	6.05
Other Long-Term Liabilities	-0	0	-	-	-
Total Liabilities	215.96	17.57	30.77	28.81	17.4
Common Stock	550	550	550	550	550
Additional Paid-In Capital	-	44	44	44	44
Retained Earnings	-	-32.31	-26.47	-24.51	-11.59
Comprehensive Income & Other	-545.65	-	-	-	-
Shareholders' Equity	4.35	561.69	567.53	569.49	582.41
Total Liabilities & Equity	220.31	579.26	598.3	598.3	599.81
Total Debt	214.02	6.05	19.5	19.05	6.05
Net Cash (Debt)	-190.96	-5.91	-19.49	-19.04	-5.65
Net Cash Per Share	-0.35	-0.01	-0.04	-0.03	-0.01
Filing Date Shares Outstanding	550.6	550	550	550	550
Total Common Shares Outstanding	550.6	550	550	550	550
Working Capital	21.12	2.13	-11.25	-9.74	-0.44
Book Value Per Share	0.01	1.02	1.03	1.04	1.06
Tangible Book Value	4.35	561.69	567.53	569.49	582.41
Tangible Book Value Per Share	0.01	1.02	1.03	1.04	1.06